Using Kaplan-Meier survival analysis, we showed that the low expression of miR-106a-5p or the increased expression of FASTK is significantly associated with poor survival outcome in astrocytoma patients. The gene discussed is FASTK; the disease is astrocytoma (excluding glioblastoma).